View Our Latest Analysis on C4 TherapeuticsC4 Therapeutics Stock Down 3.2%C4 Therapeutics stock opened at $2.15 on Monday. C4 Therapeutics has a 12 month low of $1.09 and a 12 month high of $7.14. C4 Therapeutics had a negative net margin of 325.88% and a negative return on equity of 53.91%. On average, equities research analysts expect that C4 Therapeutics will post -1.52 earnings per share for the current fiscal year. Further ReadingReceive News & Ratings for C4 Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C4 Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.